These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34768205)

  • 1. Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase.
    Yapar G; Esra Duran H; Lolak N; Akocak S; Türkeş C; Durgun M; Işık M; Beydemir Ş
    Bioorg Chem; 2021 Dec; 117():105473. PubMed ID: 34768205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors.
    Demir Y; Tokalı FS; Kalay E; Türkeş C; Tokalı P; Aslan ON; Şendil K; Beydemir Ş
    Mol Divers; 2023 Aug; 27(4):1713-1733. PubMed ID: 36103032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3H)-one derivatives as potential aldose reductase inhibitors.
    Tokalı FS; Demir Y; Demircioğlu İH; Türkeş C; Kalay E; Şendil K; Beydemir Ş
    Drug Dev Res; 2022 May; 83(3):586-604. PubMed ID: 34585414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
    Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
    Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK; Sundaram K; Ravi S
    Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
    Mohd Siddique MU; Thakur A; Shilkar D; Yasmin S; Halakova D; Kovacikova L; Prnova MS; Stefek M; Acevedo O; Dasararaju G; Devadasan V; Mondal SK; Jayaprakash V
    Eur J Med Chem; 2021 Nov; 223():113630. PubMed ID: 34175538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket.
    Hlaváč M; Kováčiková L; Šoltésová Prnová M; Addová G; Hanquet G; Štefek M; Boháč A
    Bioorg Med Chem; 2021 Jan; 29():115885. PubMed ID: 33271452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new series of hydrazones as small-molecule aldose reductase inhibitors.
    Altıntop MD; Demir Y; Türkeş C; Öztürk RB; Cantürk Z; Beydemir Ş; Özdemir A
    Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200570. PubMed ID: 36603162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, molecular modeling, selective aldose reductase inhibition and hypoglycemic activity of novel meglitinides.
    Salem MG; Abdel Aziz YM; Elewa M; Nafie MS; Elshihawy HA; Said MM
    Bioorg Chem; 2021 Jun; 111():104909. PubMed ID: 33895603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications.
    Vyas B; Choudhary S; Singh PK; Kumar M; Verma H; Singh M; Malik AK; Silakari O
    Bioorg Chem; 2020 Mar; 96():103570. PubMed ID: 31978681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
    Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
    Zhu S; Zhang S; Hao X; Qin X; Parveen S; Yang S; Ma B; Zhu C
    J Enzyme Inhib Med Chem; 2016; 31(sup1):126-130. PubMed ID: 27153454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
    Imran A; Tariq Shehzad M; Al Adhami T; Miraz Rahman K; Hussain D; Alharthy RD; Shafiq Z; Iqbal J
    Bioorg Chem; 2021 Oct; 115():105164. PubMed ID: 34314916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
    Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
    Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
    Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
    Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition.
    Shehzad MT; Hameed A; Al-Rashida M; Imran A; Uroos M; Asari A; Mohamad H; Islam M; Iftikhar S; Shafiq Z; Iqbal J
    Bioorg Chem; 2019 Nov; 92():103244. PubMed ID: 31541804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications.
    Kumar M; Choudhary S; Singh PK; Silakari O
    Future Med Chem; 2020 Jul; 12(14):1327-1358. PubMed ID: 32602375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
    Huang W; Zhang Y; Liang X; Yang L
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (5-Hydroxy-4-oxo-2-styryl-4
    Chen H; Zhang X; Zhang X; Liu W; Lei Y; Zhu C; Ma B
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33158254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.